Andrea Schütz

Prager Dreifuss is proud to announce that our colleagues Andrea Schütz, Christian Schönfeld and Marcel Frey have been recognised by Mondaq as thought leaders in the area of Food, Drugs, Healthcare and Life Sciences in Switzerland in its autumn 2023 awards.

Admission AOS En raison des nouvelles restrictions d’admission des médecins, il devient plus difficile de reprendre un cabinet médical. Qui souhaite acheter ou vendre un cabinet ne devrait pas régler le transfert du numéro RCC, mais celui de l’admission AOS. Il appartient aux cantons de décider si et comment les admissions AOS peuvent être transférées. Un aperçu de la situation juridique actuelle.

A stable and comprehensible legal framework is of great importance, not only in crisis situations, but in general. Legal uncertainties are poison for the supply of a country with important medical goods. The life sciences sector has so far not raised any major competition law issues in Switzerland. Yet, recent jurisprudence as well as enacted and planned legislative amendments are not free of contradictions and ambiguities. The lack of an update of the Mutual Recognition Agreement and the related status of Switzerland as a third country vis-à-vis the EU brought additional uncertainties. The authors provide an overview of the current regulatory environment and discuss the implications of planned legislative changes.

The "Internet of Things" (IoT) causes our private life to increasingly become part of the Internet. Nevertheless, many IoT applications do not meet the requirements of data protection law. In this publication, the authors Dr Andrea Schütz and Dr Christian Schönfeld illustrate that data protection law is not just a regulatory hurdle, but can also be used as a potential competitive advantage.

After Switzerland's designation as a "third country" by the EU, the Swiss medtech industry faces two existential challenges. On the one hand, it must ensure the sustainable supply of medical devices to the Swiss population. On the other hand, it must maintain the competitiveness and innovative strength of Switzerland in the global medical market. This article illustrates the challenges but also the opportunities for the Swiss and foreign medtech industry related to the "third country" status of Switzerland.

For a number of reasons, it is not certain that sufficient medical devices will be available to supply the Swiss population in the coming years. This publication intends to show healthcare institutions and healthcare professionals the legal instruments available to them to prevent supply shortages and to make concrete recommendations for action. It also serves as an appeal to politicians and health authorities to proactively address the issue of supply shortages of medical devices, including in vitro diagnostic medical devices.

Only the first page of the article of the current edition of the journal «Aktuelle juristische Praxis» (AJP) is published.

From our Health and Medical Law Team: In the current edition of the Schweizerische Ärztezeitung (SÄZ), Dr Andrea Schütz provides physicians with information on how they can defend themselves against unacceptable methods of health insurers.(original article in German)

News from our Start Up Desk: in the current issue of Ladies Drive Andrea Schütz and Rahel Nedi discuss their commitment for Female Founders

After various shocking incidents involving medical devices, numerous calls were made for stricter measures to increase safety and protect public health. As a result, medical device legislation in both the EU and Switzerland has been thoroughly revised. Andrea Schütz' article critically examines whether the numerous legislative adjustments will actually lead to an improvement in the quality and safety of medical devices. (PDF available in German only.)